 Jose Diaz-Miron
Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 2 | 2026 | 125 | 1.680 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2025 | 383 | 1.320 |
Why?
| | Gastrostomy | 7 | 2026 | 130 | 1.270 |
Why?
| | Surgeons | 6 | 2025 | 339 | 1.200 |
Why?
| | Intestine, Small | 8 | 2017 | 166 | 1.110 |
Why?
| | Appendicitis | 3 | 2025 | 148 | 1.060 |
Why?
| | Preoperative Care | 2 | 2026 | 379 | 0.970 |
Why?
| | Intubation, Gastrointestinal | 2 | 2026 | 82 | 0.960 |
Why?
| | Funnel Chest | 4 | 2026 | 29 | 0.920 |
Why?
| | Minimally Invasive Surgical Procedures | 4 | 2026 | 192 | 0.830 |
Why?
| | Renal Insufficiency | 1 | 2025 | 168 | 0.780 |
Why?
| | Central Venous Catheters | 1 | 2023 | 52 | 0.780 |
Why?
| | Intestinal Atresia | 1 | 2023 | 17 | 0.770 |
Why?
| | Catheter-Related Infections | 1 | 2023 | 94 | 0.750 |
Why?
| | Enteral Nutrition | 7 | 2026 | 216 | 0.750 |
Why?
| | Needs Assessment | 1 | 2025 | 404 | 0.740 |
Why?
| | Clinical Decision-Making | 1 | 2025 | 359 | 0.710 |
Why?
| | Catheterization, Central Venous | 1 | 2023 | 122 | 0.710 |
Why?
| | Myofibromatosis | 1 | 2021 | 10 | 0.710 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2025 | 340 | 0.700 |
Why?
| | Heart Arrest | 1 | 2025 | 407 | 0.670 |
Why?
| | Child | 29 | 2026 | 22633 | 0.650 |
Why?
| | Wounds and Injuries | 3 | 2026 | 956 | 0.640 |
Why?
| | Decision Making | 2 | 2025 | 975 | 0.640 |
Why?
| | Retrospective Studies | 24 | 2026 | 17066 | 0.630 |
Why?
| | Adaptation, Physiological | 6 | 2017 | 570 | 0.620 |
Why?
| | Infant, Newborn | 9 | 2026 | 6429 | 0.550 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 428 | 0.550 |
Why?
| | Infant | 17 | 2026 | 10034 | 0.530 |
Why?
| | Neovascularization, Physiologic | 3 | 2015 | 194 | 0.510 |
Why?
| | Telemedicine | 3 | 2026 | 945 | 0.510 |
Why?
| | Short Bowel Syndrome | 5 | 2017 | 27 | 0.470 |
Why?
| | Clinical Protocols | 3 | 2026 | 282 | 0.460 |
Why?
| | Child, Preschool | 14 | 2026 | 11787 | 0.450 |
Why?
| | Esophageal Atresia | 2 | 2026 | 30 | 0.440 |
Why?
| | Lung Diseases | 1 | 2022 | 787 | 0.440 |
Why?
| | Tracheoesophageal Fistula | 2 | 2026 | 38 | 0.440 |
Why?
| | Coronary Aneurysm | 1 | 2014 | 14 | 0.420 |
Why?
| | Quality Improvement | 1 | 2023 | 1289 | 0.420 |
Why?
| | Appendectomy | 2 | 2025 | 89 | 0.420 |
Why?
| | Length of Stay | 5 | 2026 | 1337 | 0.400 |
Why?
| | Hepatoblastoma | 2 | 2024 | 52 | 0.400 |
Why?
| | Thoracic Injuries | 1 | 2014 | 72 | 0.400 |
Why?
| | Baseball | 1 | 2014 | 57 | 0.400 |
Why?
| | Specialties, Surgical | 2 | 2025 | 82 | 0.390 |
Why?
| | Humans | 44 | 2026 | 144759 | 0.390 |
Why?
| | Male | 30 | 2026 | 72315 | 0.380 |
Why?
| | Hemostasis | 1 | 2013 | 102 | 0.380 |
Why?
| | Postoperative Complications | 7 | 2026 | 2919 | 0.370 |
Why?
| | Hematopoiesis | 1 | 2013 | 194 | 0.370 |
Why?
| | Surgical Wound Infection | 2 | 2026 | 316 | 0.360 |
Why?
| | Female | 29 | 2026 | 78271 | 0.360 |
Why?
| | Adolescent | 15 | 2026 | 22428 | 0.340 |
Why?
| | Wounds, Nonpenetrating | 1 | 2014 | 316 | 0.330 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3863 | 0.320 |
Why?
| | Patient Education as Topic | 2 | 2026 | 780 | 0.310 |
Why?
| | Lung | 1 | 2022 | 4109 | 0.280 |
Why?
| | Intestinal Mucosa | 5 | 2017 | 676 | 0.260 |
Why?
| | Liver Neoplasms | 2 | 2024 | 780 | 0.260 |
Why?
| | Treatment Outcome | 7 | 2026 | 11679 | 0.260 |
Why?
| | Laparoscopy | 3 | 2026 | 475 | 0.250 |
Why?
| | Gastropexy | 1 | 2026 | 4 | 0.240 |
Why?
| | Trauma Centers | 3 | 2026 | 462 | 0.240 |
Why?
| | Receptor, IGF Type 1 | 2 | 2017 | 64 | 0.240 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2017 | 24 | 0.240 |
Why?
| | Intercostal Nerves | 1 | 2025 | 2 | 0.230 |
Why?
| | Retinoblastoma Protein | 2 | 2017 | 61 | 0.230 |
Why?
| | Hypesthesia | 1 | 2025 | 21 | 0.230 |
Why?
| | Hernia, Inguinal | 1 | 2025 | 43 | 0.230 |
Why?
| | Operative Time | 1 | 2026 | 175 | 0.230 |
Why?
| | Gastroschisis | 1 | 2025 | 32 | 0.230 |
Why?
| | Herniorrhaphy | 1 | 2025 | 74 | 0.220 |
Why?
| | Cryosurgery | 1 | 2025 | 47 | 0.220 |
Why?
| | Sutures | 1 | 2025 | 64 | 0.220 |
Why?
| | Caregivers | 2 | 2026 | 1049 | 0.220 |
Why?
| | Chemokine CXCL5 | 2 | 2015 | 19 | 0.220 |
Why?
| | Trisomy 18 Syndrome | 1 | 2024 | 5 | 0.210 |
Why?
| | Anastomotic Leak | 1 | 2024 | 44 | 0.210 |
Why?
| | Intestinal Volvulus | 1 | 2024 | 23 | 0.210 |
Why?
| | Suture Techniques | 1 | 2025 | 131 | 0.210 |
Why?
| | Hospitals, Pediatric | 2 | 2025 | 556 | 0.210 |
Why?
| | Competency-Based Education | 1 | 2025 | 79 | 0.210 |
Why?
| | Gastric Fistula | 1 | 2024 | 9 | 0.210 |
Why?
| | Critical Pathways | 1 | 2025 | 108 | 0.210 |
Why?
| | Health Literacy | 1 | 2026 | 184 | 0.200 |
Why?
| | Drug Prescriptions | 1 | 2025 | 284 | 0.200 |
Why?
| | Prospective Studies | 4 | 2026 | 7990 | 0.190 |
Why?
| | Pandemics | 2 | 2022 | 1694 | 0.190 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2023 | 21 | 0.190 |
Why?
| | Postoperative Care | 1 | 2025 | 288 | 0.190 |
Why?
| | Enoxaparin | 1 | 2023 | 67 | 0.190 |
Why?
| | Perioperative Care | 1 | 2025 | 231 | 0.180 |
Why?
| | Tomography, X-Ray Computed | 2 | 2023 | 2730 | 0.180 |
Why?
| | False Positive Reactions | 1 | 2022 | 121 | 0.170 |
Why?
| | Scalp | 1 | 2021 | 37 | 0.170 |
Why?
| | Interviews as Topic | 1 | 2025 | 901 | 0.170 |
Why?
| | Photography | 1 | 2021 | 115 | 0.170 |
Why?
| | Intestinal Obstruction | 1 | 2021 | 56 | 0.160 |
Why?
| | Fellowships and Scholarships | 1 | 2025 | 357 | 0.160 |
Why?
| | Guideline Adherence | 1 | 2025 | 589 | 0.160 |
Why?
| | Operating Rooms | 1 | 2022 | 146 | 0.160 |
Why?
| | Transgender Persons | 1 | 2023 | 191 | 0.160 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2024 | 370 | 0.160 |
Why?
| | Healthcare Disparities | 2 | 2024 | 727 | 0.150 |
Why?
| | Referral and Consultation | 1 | 2026 | 851 | 0.150 |
Why?
| | Education, Medical, Graduate | 1 | 2025 | 557 | 0.150 |
Why?
| | Pregnancy Outcome | 1 | 2023 | 476 | 0.150 |
Why?
| | Thrombosis | 1 | 2023 | 393 | 0.150 |
Why?
| | Neuroblastoma | 2 | 2011 | 174 | 0.140 |
Why?
| | Mice, Knockout | 5 | 2017 | 3121 | 0.130 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 609 | 0.130 |
Why?
| | Qualitative Research | 1 | 2025 | 1671 | 0.130 |
Why?
| | Feasibility Studies | 1 | 2022 | 1095 | 0.130 |
Why?
| | Patient Satisfaction | 1 | 2021 | 704 | 0.130 |
Why?
| | Infant, Premature | 1 | 2021 | 611 | 0.130 |
Why?
| | Analgesics, Opioid | 1 | 2025 | 1143 | 0.130 |
Why?
| | Sensitivity and Specificity | 1 | 2022 | 1985 | 0.130 |
Why?
| | Clinical Competence | 1 | 2025 | 1244 | 0.120 |
Why?
| | Pediatrics | 1 | 2025 | 1114 | 0.120 |
Why?
| | Curriculum | 1 | 2023 | 1059 | 0.120 |
Why?
| | Practice Patterns, Physicians' | 1 | 2025 | 1356 | 0.120 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 914 | 0.120 |
Why?
| | Head and Neck Neoplasms | 1 | 2021 | 558 | 0.120 |
Why?
| | Parents | 1 | 2025 | 1403 | 0.120 |
Why?
| | Incidence | 1 | 2023 | 2879 | 0.120 |
Why?
| | Burnout, Professional | 1 | 2022 | 484 | 0.110 |
Why?
| | Mice, Inbred C57BL | 6 | 2015 | 5992 | 0.110 |
Why?
| | Thoracoscopy | 2 | 2026 | 62 | 0.110 |
Why?
| | Enterocytes | 1 | 2014 | 16 | 0.110 |
Why?
| | Intestinal Absorption | 1 | 2015 | 103 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1907 | 0.100 |
Why?
| | Vitamin K Deficiency Bleeding | 1 | 2013 | 4 | 0.100 |
Why?
| | Extracorporeal Circulation | 1 | 2013 | 15 | 0.100 |
Why?
| | Digestive System Surgical Procedures | 1 | 2014 | 109 | 0.100 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2013 | 32 | 0.100 |
Why?
| | Dietary Proteins | 1 | 2014 | 136 | 0.100 |
Why?
| | Body Composition | 2 | 2014 | 706 | 0.100 |
Why?
| | Injury Severity Score | 2 | 2026 | 600 | 0.100 |
Why?
| | Intracranial Hemorrhages | 1 | 2013 | 100 | 0.100 |
Why?
| | Diet, High-Fat | 1 | 2014 | 261 | 0.090 |
Why?
| | ErbB Receptors | 1 | 2015 | 627 | 0.090 |
Why?
| | Weight Gain | 1 | 2014 | 556 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2011 | 66 | 0.080 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2017 | 341 | 0.080 |
Why?
| | Imidazoles | 1 | 2011 | 254 | 0.080 |
Why?
| | Pregnancy | 1 | 2023 | 7190 | 0.080 |
Why?
| | Neovascularization, Pathologic | 1 | 2011 | 286 | 0.070 |
Why?
| | Angiogenesis Inhibitors | 1 | 2011 | 237 | 0.070 |
Why?
| | Patient Readmission | 2 | 2025 | 758 | 0.070 |
Why?
| | Piperazines | 1 | 2011 | 381 | 0.070 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2011 | 557 | 0.070 |
Why?
| | Animals | 9 | 2017 | 38058 | 0.070 |
Why?
| | Bacteria | 1 | 2014 | 889 | 0.070 |
Why?
| | RNA | 1 | 2014 | 940 | 0.060 |
Why?
| | Microbiota | 1 | 2014 | 781 | 0.060 |
Why?
| | Neoplasm Proteins | 1 | 2009 | 442 | 0.060 |
Why?
| | Parenteral Nutrition, Total | 1 | 2026 | 30 | 0.060 |
Why?
| | Thoracic Wall | 1 | 2025 | 21 | 0.060 |
Why?
| | Selenium | 1 | 2025 | 49 | 0.060 |
Why?
| | Cellulitis | 1 | 2025 | 53 | 0.060 |
Why?
| | Postoperative Period | 2 | 2017 | 354 | 0.050 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2011 | 985 | 0.050 |
Why?
| | Mice | 7 | 2017 | 18339 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2608 | 0.050 |
Why?
| | Antibiotic Prophylaxis | 1 | 2025 | 129 | 0.050 |
Why?
| | Asymptomatic Diseases | 1 | 2024 | 102 | 0.050 |
Why?
| | Radiation Exposure | 1 | 2024 | 63 | 0.050 |
Why?
| | Anastomosis, Surgical | 1 | 2024 | 157 | 0.050 |
Why?
| | Random Allocation | 2 | 2014 | 363 | 0.050 |
Why?
| | Shock | 1 | 2024 | 108 | 0.050 |
Why?
| | Disease Models, Animal | 4 | 2014 | 4557 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2009 | 1166 | 0.050 |
Why?
| | Gender Identity | 1 | 2023 | 121 | 0.050 |
Why?
| | Disposable Equipment | 1 | 2022 | 24 | 0.050 |
Why?
| | Recurrence | 1 | 2025 | 1135 | 0.050 |
Why?
| | Reoperation | 1 | 2025 | 630 | 0.050 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2025 | 279 | 0.040 |
Why?
| | Heparin | 1 | 2023 | 244 | 0.040 |
Why?
| | Adhesives | 1 | 2021 | 15 | 0.040 |
Why?
| | Hospital Costs | 1 | 2022 | 124 | 0.040 |
Why?
| | Adenoidectomy | 1 | 2022 | 81 | 0.040 |
Why?
| | Contrast Media | 1 | 2024 | 488 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2023 | 268 | 0.040 |
Why?
| | Cardiology | 1 | 2024 | 353 | 0.040 |
Why?
| | Tissue Adhesions | 1 | 2021 | 34 | 0.040 |
Why?
| | Cell Proliferation | 3 | 2015 | 2496 | 0.040 |
Why?
| | United States | 3 | 2024 | 15966 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2014 | 1716 | 0.040 |
Why?
| | Intestines | 1 | 2023 | 358 | 0.040 |
Why?
| | Medicaid | 1 | 2024 | 461 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2024 | 1326 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1886 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 6048 | 0.040 |
Why?
| | Young Adult | 2 | 2026 | 14105 | 0.040 |
Why?
| | Databases, Factual | 1 | 2024 | 1486 | 0.030 |
Why?
| | Apoptosis | 2 | 2015 | 2430 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2014 | 2832 | 0.030 |
Why?
| | Sodium-Glucose Transporter 1 | 1 | 2014 | 11 | 0.030 |
Why?
| | Glucose Transporter Type 2 | 1 | 2014 | 16 | 0.030 |
Why?
| | Fish Oils | 1 | 2014 | 26 | 0.030 |
Why?
| | Tissue and Organ Harvesting | 1 | 2014 | 73 | 0.030 |
Why?
| | Time Factors | 1 | 2024 | 7173 | 0.020 |
Why?
| | Tamoxifen | 1 | 2014 | 217 | 0.020 |
Why?
| | Microcirculation | 1 | 2014 | 138 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 1185 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2024 | 5868 | 0.020 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2014 | 142 | 0.020 |
Why?
| | Colorado | 1 | 2023 | 4564 | 0.020 |
Why?
| | Cell Line, Tumor | 2 | 2011 | 3540 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 854 | 0.020 |
Why?
| | Blotting, Western | 1 | 2014 | 1187 | 0.020 |
Why?
| | Energy Intake | 1 | 2014 | 499 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 851 | 0.020 |
Why?
| | Bevacizumab | 1 | 2011 | 167 | 0.020 |
Why?
| | Risk Factors | 1 | 2024 | 10779 | 0.020 |
Why?
| | Mice, Nude | 1 | 2011 | 682 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 138 | 0.020 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 297 | 0.020 |
Why?
| | Adult | 2 | 2023 | 40449 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 175 | 0.020 |
Why?
| | Down-Regulation | 1 | 2011 | 627 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 173 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2015 | 1125 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2011 | 688 | 0.020 |
Why?
| | Weight Loss | 1 | 2014 | 836 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2011 | 928 | 0.020 |
Why?
| | Transfection | 1 | 2009 | 940 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2011 | 529 | 0.020 |
Why?
| | Base Sequence | 1 | 2009 | 2190 | 0.010 |
Why?
| | Biomarkers | 1 | 2017 | 4271 | 0.010 |
Why?
| | Phosphorylation | 1 | 2009 | 1732 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2930 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2014 | 5408 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2011 | 1455 | 0.010 |
Why?
| | Computational Biology | 1 | 2009 | 680 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2009 | 4154 | 0.010 |
Why?
|
|
Diaz-Miron's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|